Q: WHICH CONSUMER STOCK MONDELEZ OR KENVUE WOULD BE BETTER NOW AND GOING FORWARD FOR THE FUTURE?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: You had a few comments about this this stock in the past month; one suggesting it being a buyable option below $152.
RBC Capital Markets has a $336 USD Target price and it sits on their Top 30 Global Ideas list. Morningstar rating is 5 with a Fair Value est. of $269. Currently seems to be a Hold among analysts. You have already some comments on recent corporate performance.
There is some noise of legal class action, yet not sure how significant this would be or whether it creates a drag on the stock. Add to the mix a new CEO.
I'd be very interested in your take on this stock given the above and its' meltdown with the market. Thanks, as always, for your insights.
RBC Capital Markets has a $336 USD Target price and it sits on their Top 30 Global Ideas list. Morningstar rating is 5 with a Fair Value est. of $269. Currently seems to be a Hold among analysts. You have already some comments on recent corporate performance.
There is some noise of legal class action, yet not sure how significant this would be or whether it creates a drag on the stock. Add to the mix a new CEO.
I'd be very interested in your take on this stock given the above and its' meltdown with the market. Thanks, as always, for your insights.
Q: What’s going on with Stryker, it’s on a significant downward trend?
Q: Can you give me an update on this stock and whether you would hold.It has come up nice lately
Q: Hi 5i,
I found the Q&A about Envista this morning very interesting. With the Veralto spinoff that is happening with DHR, do you think that Veralto will have the same low/no growth issues? I think DHR is trying to do the same again by keeping the higher growth assets and spinning off the lower growth ones. Would you hang on the the new shares when received or would you sell and maybe put back into DHR instead? TIA!
Wayne
I found the Q&A about Envista this morning very interesting. With the Veralto spinoff that is happening with DHR, do you think that Veralto will have the same low/no growth issues? I think DHR is trying to do the same again by keeping the higher growth assets and spinning off the lower growth ones. Would you hang on the the new shares when received or would you sell and maybe put back into DHR instead? TIA!
Wayne
Q: WELL Health seems to have a problem releasing their quarterly results in a timely fashion. Is there an acceptable reason for this or is this an indication poor management.
Q: Have been looking at this for a month or two and would like your thoughts and analysis please.
Is it worth a small 1% gamble?
Is it worth a small 1% gamble?
Q: I know this is a small cap but I took a shot and now regret it. Do you see any signs of hope for this one? They recently spun off a part of the company. Is there any enhanced value in the move or is it price neutral?
Q: I'm down on all three of these stocks in my TFSA. Do you see any upside to these companies, or should I bail on them?
thank you
thank you
Q: Down 28 percent. Is it a hold or sell and buy a different stock. I can also add more if the future prospect is good.
It is in my rrsp.
Thanks
It is in my rrsp.
Thanks
-
Amgen Inc. (AMGN)
-
Intuitive Surgical Inc. (ISRG)
-
AbbVie Inc. (ABBV)
-
Eli Lilly and Company (LLY)
-
Medtronic plc. (MDT)
-
Lantheus Holdings Inc. (LNTH)
Q: Hi 5i,
I currently have no healthcare holdings and should be at about 9%. Could you please give me some suggested opportunities?
As always, many thanks
I currently have no healthcare holdings and should be at about 9%. Could you please give me some suggested opportunities?
As always, many thanks
Q: What is going on? The stock is up 25%
Q: Hi,
What's your thoughts on this company at this time?
Thanks
What's your thoughts on this company at this time?
Thanks
Q: Share price is still falling like a rock ever since reporting good numbers… what gives? Thanks
Q: Thoughts on whether this stock is a buy/sell/hold...thanks.
Q: Been some time since a Q was asked about this company - please provide your thoughts on its valuation (particularly relative to peers) and growth prospects going forward. Thx for all you do, John
-
Illumina Inc. (ILMN)
-
Pacific Biosciences of California Inc. (PACB)
-
Exact Sciences Corporation (EXAS)
Q: I haven't seen any questions on this company for a while. Please provide your assessment of its prospects. Is it a buy at current rates? Please provide two or three other prospects in this space.
Thanks,
Fred
Thanks,
Fred
-
Savaria Corporation (SIS)
-
Currency Exchange International Corp. (CXI)
-
WELL Health Technologies Corp. (WELL)
Q: I have held SIS for a number of years and although I have enjoyed the dividend, the share price never seems to hold its momentum and drifts back to the low/mid teens where I bought it. I like the dividends but value total return more. I have never owned WELL but have followed it based on your recommendation. Can you rank the two and provide a short explanation as to your preference on the following metrics: 1) Management 2) Balance Sheet 3) Profitability 4) Long Term (5-10 yr) Return Potential and 5) Risk
I would prefer to hold just one of them.
Secondly, what is your analysis of CXI's quarter.
Many Thanks
Scott
I would prefer to hold just one of them.
Secondly, what is your analysis of CXI's quarter.
Many Thanks
Scott
Q: your thoughts please with savaria now below the $14.50 offer price for there latest stock offering?
Thx
Thx
Q: Considering the dramatic rise in LLY's SP this year, is there more room to run. Thinking of switching ABBV for LLY. Thoughts?
Carl
Carl